New York City Department of Health and Mental Hygiene   Report issue

Government Phase 2 Phase 3
Founded: New York City NY United States (1870)

Organization Overview

First Clinical Trial
2006
NCT00367302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

New York City Department of Health and Mental Hygiene

Active Ingredients

Drugs in Phase 3 Trials (1)

naltrexone (revia) (1 trial)

Drugs in Phase 2 Trials (2)

buprenorphine (1 trial)

methadone (methadose) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Behavior, Addictive (Phase 2)

Opioid-Related Disorders (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3